ENDO 2024 press conferences to highlight male birth control, anti-obesity medications

Researchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences June 1-4.

Mount Sinai Experts Available for Interview During Endometriosis Awareness Month

Contact: Stacy A. Anderson                     Mount Sinai Press Office                     347-346-3390                     [email protected]                            (New York, NY – March 21, 2024) – As we continue to recognize March as Endometriosis Awareness Month, observed to bring attention to the…

Excess Testosterone Can Lead to Increased Cardiovascular Risks in People with Polycystic Ovary Syndrome

Article title: Testosterone-associated blood pressure dysregulation in women with androgen excess polycystic ovary syndrome Authors: Tori Stone, Licy L. Yanes Cardozo, Toni N. Oluwatade, Cheryl A. Leone, Melanie Burgos, Faith Okifo, Lubna Pal, Jane F. Reckelhoff, Nina. S. Stachenfeld From…

Researchers Develop AI Model to Better Predict Which Drugs May Cause Birth Defects

Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues have created an artificial intelligence model that may more accurately predict which existing medicines, not currently classified as harmful, may in fact lead to congenital disabilities. The model, or “knowledge graph,” described in the July 17 issue of the Nature journal Communications Medicine, also has the potential to predict the involvement of pre-clinical compounds that may harm the developing fetus. The study is the first known of its kind to use knowledge graphs to integrate various data types to investigate the causes of congenital disabilities.

Pediatrics expert available to comment on FDA approval of first OTC birth control pill

Tracey Wilkinson, an associate professor of pediatrics at the Indiana University School of Medicine, is available to comment on FDA approval of the first over-the-counter birth control pill. She was on the HRA Pharma (maker of the Opill) expert panel…

Women with polycystic ovary syndrome may face increased risk of death

People with polycystic ovary syndrome (PCOS) have a 47% increased risk for death at a younger age compared with those without the condition, according to research being presented on Sunday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Body image concerns significantly higher in women living with PCOS

Women living with polycystic ovary syndrome (PCOS) experience greater body image concerns than individuals without the condition, according to research being presented Saturday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Mount Sinai Experts Present New Research at 70th Annual Meeting of the Society for Reproductive Investigation

Reproductive health experts from the Mount Sinai Health System are presenting research at the 70th Annual Meeting of the Society for Reproductive Investigation (SRI) in Brisbane, Australia from March 21-25.

Cannabis use in adolescent years may create reproductive complications in women, according to a UC Irvine study

In a new study, University of California, Irvine researchers found that exposure to the compound tetrahydrocannabinol (THC), a component of cannabis, at a young age could lead to depleted ovarian follicles and matured eggs in adulthood by nearly 50 percent.

Youngest Girls Who Get Pregnant Have Highest Risk of Poor Outcomes, Study Finds

Pregnant teens in the U.S. have long been known to face increased health risks and pregnancy complications, but a new study for the first time finds that girls ages 13 or younger who get pregnant face even greater risks. These very young girls are significantly more likely to experience preterm birth, cesarean delivery, and admission to the intensive care unit (ICU) compared to older pregnant teens.

Rutgers expert, author of “Abortion after Roe” available for comment on abortion decision

“Abortion is – and always has been – a key arena for contesting power relations between women and men.  While the decriminalization of abortion made the procedure legal and safe and helped women to gain access to education and careers,…

Testosterone improves quality of life, sexual function, and delayed verbal recall in men with uncontrolled type 2 diabetes

Testosterone replacement therapy improved sexual symptoms, libido, symptom severity, delayed verbal recall and overall quality of life among people with poorly controlled type 2 diabetes and hypogonadism, according to research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Suppressed ovarian follicle development in women with obesity may explain reduced fertility

Women with obesity, even those with regular menstrual cycles, have suppressed ovarian follicle development and reduced production of reproductive hormones, which may underlie reduced fertility, according to a new study being presented Saturday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Supreme Court leaked abortion draft: U-M experts can comment on political, health effects

The U.S. Supreme Court acknowledged a leaked draft opinion on Roe v. Wade, the landmark 1973 court decision that granted federal protection of abortion rights. The University of Michigan has experts who can weigh in on the potential decision, which is expected to be formally announced before the term ends this summer.

For comment on restrictive abortion laws: Natali Valdez, author of Weighing the Future: Race, Science, and Pregnancy Trials in the Postgenomic Era

As the court battle over the abortion law in Texas continues, Wellesley College women and gender studies professor Natali Valdez is available for comment on how the situation in Texas reveals how unconstitutional restrictions on individual liberties are permitted, promoted, and…

The Challenge Initiative at the Bloomberg School of Public Health Receives Two Grants to Support Family Planning for Women and Girls in Poor Urban Areas

The Challenge Initiative (TCI), a global initiative based at the Johns Hopkins Bloomberg School of Public Health that supports the reproductive health needs of women and girls living in poor urban communities in Africa and Asia, has received grants totaling $18.1 million from Bayer AG and the Bill & Melinda Gates Foundation.

Sylvester Comprehensive Cancer Center Urologist Leads Collaborative Study on Fertility Counseling Prior to Chemotherapy

For younger cancer patients, fertility counseling at the time of cancer diagnosis is important for making family planning decisions. Ranjith Ramasamy, M.D., a clinician and researcher at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was the lead author of a new collaborative study, “Evaluation of Reported Fertility Preservation Counseling Before Chemotherapy Using the Quality Oncology Practice Initiative Survey,” published JAMA Network Open.

How the Pandemic Affects Adolescent and Young Adults Sexual and Reproductive Health

The COVID-19 pandemic is affecting the sexual and reproductive health of adolescents and young adults because of social distancing as well as limited access to contraceptive and abortion care, according to a sexual and reproductive health researcher at the Rutgers School of Public Health who recently published an article on the topic.

Leslie Kantor, a professor and chair of the Rutgers Department of Urban Global Public Health, addresses how these challenges, as well as peer and romantic relationships, are being navigated.

Heatwave Exposure Linked to Increased Risk of Preterm Birth in California

A new study at UC San Diego, published February 11, 2020, found that exposure to heatwaves during the last week of pregnancy was strongly linked to an increased risk of preterm delivery – the hotter the temperature or the longer the heatwave, the greater the risk.

ACR Releases First Guideline to Address Reproductive Health for Patients with Rheumatic Diseases

This is the first, evidence-based guideline related to the management of reproductive health issues for all patients with rheumatic diseases. With 131 recommendations, the guideline offers general precepts that provide a foundation for its recommendations and good practice statements.